Susquehanna International Group, LLP Replimune Group, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$5.01 - $9.46 $250,500 - $473,000	-50,000 Reduced 67.2%	24,400 $219,000
Q1 2024 May 07, 2024	BUY	$6.87 - $9.31 $286,479 - $388,227	41,700 Added 127.52%	74,400 $607,000
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $1.93 Million - $4.62 Million	-285,500 Reduced 89.72%	32,700 $275,000
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $2.51 Million - $3.49 Million	157,500 Added 98.01%	318,200 $5.44 Million
Q2 2023 Aug 11, 2023	BUY	$15.65 - $24.1 $2.51 Million - $3.87 Million	160,700 New	160,700 $3.73 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $709M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.